- Stem Cell Therapy
- Available Treatments
- Treatment for Cancer
- Treatment for Congestive Heart Failure
- Treatment for COPD
- Treatment for Coronary Heart Disease
- Treatment for Cystic Fibrosis
- Treatment for Gangrene
- Treatment for Kidney Disease
- Treatment for Macular Degeneration
- Treatment for Orthopedic Conditions
- Treatment for Pulmonary Fibrosis
- Treatment for Pulmonary Hypertension
- Treatment for Spinal Cord Injury
- Treatment for Stargardts Disease
- Treatment for Wound Care
- Stem Cell Costs
- For Patients
- For Doctors
- How To Get Stem Cell Treatments
Leukemia researchers have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.
Two studies define how key genetic factors affect blood-forming stem cells by either accelerating or hindering the cells’ regenerative properties. The findings could one day lead to improved treatments for people undergoing common therapies for cancer such as chemotherapy and radiation, say researchers.
In a Phase I study, 8 out of 12 patients with relapsed and/or chemotherapy refractory blood cancers responded to a combination of the chemotherapy drugs thioguanine and decitabine; some of the responders had relapsed after treatment with decitabine alone, report researchers.
Preventative antibiotics could prevent Clostridium difficile infection among stem cell transplant patients
It may be possible to safely prevent one of the most common – and costly to treat – infections contracted by hospitalized patients undergoing bone marrow transplantation for the treatment of blood cancers, according to a new study.
Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse. Researchers have identified a pathway by which cancer cells aggressively spread and grow in the brain, opening up new possibilities for treatment.
Many breast cancer survivors worry that their breast cancer may come back. Recurrence has puzzled scientists and health care providers, recognizing that it can suddenly reappear, often with a vengeance, months or years after treatment is over. Now, researchers have found that dormant tumor cells might have become latent because they cannibalized–basically ate–the body’s own stem cells....
Results of a cellular therapy clinical trial for traumatic brain injury (TBI) using a patient’s own stem cells showed that the therapy appears to dampen the body’s neuroinflammatory response to trauma and preserve brain tissue, according to researchers.
Researchers have identified a molecule specifically expressed on one of the first cell populations to emerge as a precursor of the heart in embryos, which enables the cells to be isolated and studied, and potentially transplanted as a treatment for heart failure.
A possible mechanism behind the fibrosis that occurs in scleroderma has now been identified, a mechanism, researchers say, that may one day lead to a treatment for the disease.
A potential new strategy may be utilized to correct hypospadias, a birth defect which occurs when boys are born with a urinary opening on the underside of the penis, found in up to one in every 200 boys. Current treatment involves surgical reconstruction with a graft using tissue taken from the inside of a child’s cheek. This approach is associated with multiple complications and sometimes requires...